MTOR and gastric cancer: Moreover, naringin (2 μM) induced autophagy and significantly reduced gastric cancer growth by downregulating the PI3K/Akt/mTOR cascade and activating MAPKs (Table 2), suggesting its potential as a natural therapeutic enhancer in adenocarcinoma (Figure 5) [126].